257 related articles for article (PubMed ID: 18090486)
1. Injectables in the prostate.
Saemi AM; Plante MK
Curr Opin Urol; 2008 Jan; 18(1):28-33. PubMed ID: 18090486
[TBL] [Abstract][Full Text] [Related]
2. Prostatic tissue ablation by injection: a literature review.
Plante MK; Folsom JB; Zvara P
J Urol; 2004 Jul; 172(1):20-6. PubMed ID: 15201730
[TBL] [Abstract][Full Text] [Related]
3. Treatment of lower urinary tract symptoms: agents for intraprostatic injection.
Andersson KE
Scand J Urol; 2013 Apr; 47(2):83-90. PubMed ID: 23281591
[TBL] [Abstract][Full Text] [Related]
4. Relief by botulinum toxin of lower urinary tract symptoms owing to benign prostatic hyperplasia: early and long-term results.
Brisinda G; Cadeddu F; Vanella S; Mazzeo P; Marniga G; Maria G
Urology; 2009 Jan; 73(1):90-4. PubMed ID: 18995889
[TBL] [Abstract][Full Text] [Related]
5. The application of botulinum toxin in the prostate.
Chuang YC; Chancellor MB
J Urol; 2006 Dec; 176(6 Pt 1):2375-82. PubMed ID: 17085104
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia.
Antunes AA; Srougi M; Coelho RF; de Campos Freire G
Nat Clin Pract Urol; 2007 Mar; 4(3):155-60. PubMed ID: 17347660
[TBL] [Abstract][Full Text] [Related]
7. Perspective of Botox for treatment of male lower urinary tract symptoms.
Ilie CP; Chancellor MB
Curr Opin Urol; 2009 Jan; 19(1):20-5. PubMed ID: 19057212
[TBL] [Abstract][Full Text] [Related]
8. Practice patterns in benign prostatic hyperplasia surgical therapy: the dramatic increase in minimally invasive technologies.
Yu X; Elliott SP; Wilt TJ; McBean AM
J Urol; 2008 Jul; 180(1):241-5; discussion 245. PubMed ID: 18499180
[TBL] [Abstract][Full Text] [Related]
9. Transurethral ethanol injection therapy of benign prostatic hyperplasia: four-year follow-up.
Sakr M; Eid A; Shoukry M; Fayed A
Int J Urol; 2009 Feb; 16(2):196-201. PubMed ID: 19054163
[TBL] [Abstract][Full Text] [Related]
10. Is botulinum neurotoxin type A (BoNT-A) a novel therapy for lower urinary tract symptoms due to benign prostatic enlargement? A review of the literature.
Oeconomou A; Madersbacher H; Kiss G; Berger TJ; Melekos M; Rehder P
Eur Urol; 2008 Oct; 54(4):765-75. PubMed ID: 18571306
[TBL] [Abstract][Full Text] [Related]
11. New emerging technologies in benign prostatic hyperplasia.
Lusuardi L; Hruby S; Janetschek G
Curr Opin Urol; 2013 Jan; 23(1):25-9. PubMed ID: 23138466
[TBL] [Abstract][Full Text] [Related]
12. Botulinum neurotoxin A for benign prostatic hyperplasia.
Oeconomou A; Madersbacher H
Curr Opin Urol; 2010 Jan; 20(1):28-36. PubMed ID: 19887944
[TBL] [Abstract][Full Text] [Related]
13. Treatment options for benign prostatic hyperplasia in older men.
Miano R; De Nunzio C; Asimakopoulos AD; Germani S; Tubaro A
Med Sci Monit; 2008 Jul; 14(7):RA94-102. PubMed ID: 18591930
[TBL] [Abstract][Full Text] [Related]
14. Treatment options for benign prostatic hyperplasia.
Portis AJ; Mador DR
Can Fam Physician; 1997 Aug; 43():1395-404. PubMed ID: 9266125
[TBL] [Abstract][Full Text] [Related]
15. Prostatic stents for the treatment of benign prostatic hyperplasia.
Vanderbrink BA; Rastinehad AR; Badlani GH
Curr Opin Urol; 2007 Jan; 17(1):1-6. PubMed ID: 17143103
[TBL] [Abstract][Full Text] [Related]
16. Emerging Minimally Invasive Treatment Options for Male Lower Urinary Tract Symptoms.
Magistro G; Chapple CR; Elhilali M; Gilling P; McVary KT; Roehrborn CG; Stief CG; Woo HH; Gratzke C
Eur Urol; 2017 Dec; 72(6):986-997. PubMed ID: 28734706
[TBL] [Abstract][Full Text] [Related]
17. Phase I/II examination of transurethral ethanol ablation of the prostate for the treatment of symptomatic benign prostatic hyperplasia.
Plante MK; Marks LS; Anderson R; Amling C; Rukstalis D; Badlani G; Getlin L; Vang E
J Urol; 2007 Mar; 177(3):1030-5; discussion 1035. PubMed ID: 17296405
[TBL] [Abstract][Full Text] [Related]
18. Prostatic stents for benign prostatic hyperplasia.
Klein LT; Kaplan SA
J Long Term Eff Med Implants; 1997; 7(1):101-14. PubMed ID: 10168540
[TBL] [Abstract][Full Text] [Related]
19. Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients.
Reich O; Gratzke C; Bachmann A; Seitz M; Schlenker B; Hermanek P; Lack N; Stief CG;
J Urol; 2008 Jul; 180(1):246-9. PubMed ID: 18499179
[TBL] [Abstract][Full Text] [Related]
20. What's truly minimally invasive in benign prostatic hyperplasia surgery?
Chung A; Woo HH
Curr Opin Urol; 2014 Jan; 24(1):36-41. PubMed ID: 24247171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
